Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-25 @ 9:51 PM
Study NCT ID:
NCT01423851
Status:
COMPLETED
Last Update Posted:
2022-03-09
First Post:
2011-08-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Sponsor:
NS Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2020-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-15
First Submit QC Date:
None
Study First Post Date:
2011-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-12
Results First Submit QC Date:
None
Results First Post Date:
2022-03-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-09-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-02-10
Last Update Post Date:
2022-03-09
Last Update Post Date Type:
ACTUAL